Brendon Yee, PhD, professor and respiratory and sleep physician, Woolcock Institute of Medical Research, discusses the ...

We investigated synaptic plasticity in mouse OT slices by combining electrical stimulation and treatment with the appetite-promoting neuropeptide orexin, the receptors of which are highly expressed in ...

Stifel upgraded Alkermes (ALKS) to Buy from Hold with a price target of $36, up from $25. After a deep dive on the orexin space, the firm says ...

Orexin, also known as hypocretin, is a brain hormone that helps regulate sleep. A deficiency of this hormone can cause a person to develop type 1 narcolepsy. Type 1 narcolepsy, formerly known as ...

CVN293 was generally well-tolerated in healthy volunteers for up to 14-days of continuous dosingDose-dependent exposure was observed with ...

When Dr. Husseini Manji was developing the first-in-class depression medication Spravato at Johnson & Johnson he encountered plenty of naysayers.

Imagine repeatedly falling asleep or falling down paralyzed when laughing or startled. This is life with narcolepsy, which ...

Idorsia has become the first drugmaker in the EU to claim approval for a drug for chronic insomnia in the dual orexin receptor antagonist class, ahead of rival drugs from Merck & Co and Eisai.

New research links childhood adversity with later attention deficits, sleep disruptions, and specific dopamine imbalances in ...

The stocks for both Swiss and Israeli biotechs were up over 20% after the companies signed a merger agreement.

NLS Pharmaceutics shares are moving higher on Monday after the company announced it entered into a definitive merger ...

New research on the effects of adversity in childhood ties together stress, sleep loss, and attention deficits later in life.